Safety of the Use of Compressive Taping in Seroma
Seroma
About this trial
This is an interventional treatment trial for Seroma focused on measuring Taping, Seroma, Safety, Breast Cancer, Physiotherapy
Eligibility Criteria
Inclusion Criteria:
- Women who developed seroma after surgical treatment for breast cancer, detected by nursing team.
Exclusion Criteria:
- bilateral breast cancer
- neoadjuvant radiotherapy
- wound infection
- reporting of autoimmune diseases (dermatomyositis, hidradenitis suppurativa, nephropathy, lupus erythematosus, morphea, psoriasis, pemphigus vulgaris, scleroderma)
- patients with difficulties of understanding.
Sites / Locations
- Erica Alves Nogueira Fabro
Arms of the Study
Arm 1
Experimental
Intervention Vitaltape® bandage
The neuromuscular bandage will be applied after skin antisepsis with 70% alcohol. A 5 cm width Vitaltape® bandage will be used. For the bandage application, a distal base (anchor) with two centimeters of diameter will be maintained with maximum stretching on the seroma and finalized with another base no stretching, of 2 cm, in the proximal region. How many bundles of bandages are required according to the patient's body characteristics and aspect of the flotation region. The bandage will not be applied on the scar. If there are any complications such as itching, redness, discomfort and / or others, the patients will remove the material at home and communicate on return to the institution. They will remain four days approximately for revaluation and intervention suspension.